{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:02:28Z","timestamp":1791838948445,"version":"4.3.4"},"reference-count":81,"publisher":"Bioscientifica","issue":"9","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neuroendocrine neoplasms (NEN) are a rare and heterogeneous group of malignancies with rising incidence, requiring multidisciplinary and personalized management. Sex is emerging as a crucial factor in NEN development and progression. Genetic, epigenetic, and hormonal mechanisms have been proposed as potential contributors influencing treatment response and prognosis, but an in-depth analysis of the role of sex hormones and their receptors in NEN is still lacking. This review aims to analyze the impact of sex hormones and their receptors in sporadic NEN to provide potential therapeutic targets in the context of precision medicine. An overview of current preclinical and clinical evidence focused on different primary NEN, including gastroenteropancreatic, lung, prostate, and medullary thyroid cancers, focusing on estrogen, progesterone, and androgen receptors, has been made to clarify their role in NEN. Variable and conflicting results emerged across different primaries. Progesterone receptors appear to play a pivotal role in pancreatic and lung NEN, while estrogen receptors are more frequently involved in small intestine NEN and medullary thyroid carcinoma, suggesting a possible role in metastatic spread. Further studies are required to increase knowledge of the underlying mechanism of sex differences in NEN to define potential therapeutic targets for personalized care.<\/jats:p>","DOI":"10.1530\/erc-25-0164","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:40:15Z","timestamp":1758040815000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":4,"title":["Impact of sex hormones on development and progression in NEN: a new therapeutic target?"],"prefix":"10.1530","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3768-5803","authenticated-orcid":true,"given":"Roberta","family":"Modica","sequence":"first","affiliation":[{"name":"Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples 1 , ,","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Liccardi","sequence":"additional","affiliation":[{"name":"Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples 1 , ,","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zago","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Careggi University Hospital 2 , ,","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevena","family":"Mikovic","sequence":"additional","affiliation":[{"name":"Endocrinology Unit Sant\u2019Andrea Hospital, ENETS Centre of Excellence, Sapienza University of Rome 3 , ,","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Sesti","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome 4 , ,","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Ballarini","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University 5 , ,","place":["Milan, Italy"]},{"name":"Endocrinology, Diabetology and Andrology Unit, IRCCS Humanitas Research Hospital 6 , ,","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Simona","family":"Auriemma","sequence":"additional","affiliation":[{"name":"Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples 1 , ,","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[{"name":"Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples 1 , ,","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"2026070905433778600_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"2026070905433778600_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/17446651.2023.2279540","article-title":"Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms","volume":"19","author":"Modica","year":"2024","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2026070905433778600_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"key":"2026070905433778600_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40618-022-01905-4","article-title":"Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies","volume":"46","author":"Ruggeri","year":"2023","journal-title":"J Endocrinol Investig"},{"key":"2026070905433778600_bib5","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1080\/14656566.2016.1236916","article-title":"Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies","volume":"17","author":"Ito","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"2026070905433778600_bib6","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1002\/ijc.30400","article-title":"The epidemiology of metastases in neuroendocrine tumors","volume":"139","author":"Riihim\u00e4ki","year":"2016","journal-title":"Int J Cancer"},{"key":"2026070905433778600_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-021-01029-7","article-title":"Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?","volume":"23","author":"Das","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"2026070905433778600_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/17446651.2022.2099840","article-title":"Therapeutic strategies for patients with neuroendocrine neoplasms: current perspectives","volume":"17","author":"Modica","year":"2022","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2026070905433778600_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40618-021-01715-0","article-title":"Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control study","volume":"45","author":"Feola","year":"2022","journal-title":"J Endocrinol Investig"},{"key":"2026070905433778600_bib10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/metabo12111057","article-title":"Lipid metabolism and homeostasis in patients with neuroendocrine neoplasms: from risk factor to potential therapeutic target","volume":"12","author":"Modica","year":"2022","journal-title":"Metabolites"},{"key":"2026070905433778600_bib11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc.2016.30","article-title":"Sexual dimorphism in cancer","volume":"16","author":"Clocchiatti","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"2026070905433778600_bib12","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2026070905433778600_bib13","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"2026070905433778600_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000539412","article-title":"Gender differences in lung neuroendocrine tumors: a single-center experience","volume":"115","author":"Liccardi","year":"2024","journal-title":"Neuroendocrinology"},{"key":"2026070905433778600_bib15","doi-asserted-by":"crossref","first-page":"e1969","DOI":"10.1210\/clinem\/dgac001","article-title":"Sexual dimorphism in small-intestinal neuroendocrine tumors: lower prevalence of mesenteric disease in premenopausal women","volume":"107","author":"Bla\u017eevi\u0107","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070905433778600_bib16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s40618-023-02213-1","article-title":"Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study","volume":"47","author":"Ruggeri","year":"2023","journal-title":"J Endocrinol Investig"},{"key":"2026070905433778600_bib17","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae038","article-title":"Patient sex and origin influence distribution of driver genes and clinical presentation of paraganglioma","volume":"8","author":"Richter","year":"2024","journal-title":"J Endocr Soc"},{"key":"2026070905433778600_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejca.2023.04.013","article-title":"Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours","volume":"188","author":"Hernando","year":"2023","journal-title":"Eur J Cancer"},{"key":"2026070905433778600_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.6004\/jnccn.2021.7017","article-title":"Efficacy and toxicity analysis of capecitabine and temozolomide in neuroendocrine neoplasms","volume":"20","author":"Al-Toubah","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"key":"2026070905433778600_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jss.2024.07.012","article-title":"Association between female sex and better survival in gastroenteropancreatic neuroendocrine tumors","volume":"302","author":"Chang","year":"2024","journal-title":"J Surg Res"},{"key":"2026070905433778600_bib21","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3390\/cancers15061863","article-title":"Sex differences in survival from neuroendocrine neoplasia in England 2012\u20132018: a retrospective, population-based study","volume":"15","author":"White","year":"2023","journal-title":"Cancers"},{"key":"2026070905433778600_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.beem.2015.04.008","article-title":"Estrogen receptor alpha and beta in health and disease","volume":"29","author":"Jia","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026070905433778600_bib23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41574-023-00822-7","article-title":"The G protein-coupled oestrogen receptor GPER in health and disease: an update","volume":"19","author":"Prossnitz","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"2026070905433778600_bib24","doi-asserted-by":"crossref","first-page":"E3255","DOI":"10.1073\/pnas.1509322112","article-title":"Molecular transitions from papillomavirus infection to cervical precancer and cancer: role of stromal estrogen receptor signaling","volume":"112","author":"den Boon","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070905433778600_bib25","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1158\/0008-5472.CAN-06-3895","article-title":"Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers","volume":"67","author":"Gupta","year":"2007","journal-title":"Cancer Res"},{"key":"2026070905433778600_bib26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrc2174","article-title":"Treating prostate cancer: a rationale for targeting local oestrogens","volume":"7","author":"Ellem","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"2026070905433778600_bib27","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/carcin\/bgt488","article-title":"Estrogen receptor \u03b1 in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3","volume":"35","author":"Slavin","year":"2014","journal-title":"Carcinogenesis"},{"key":"2026070905433778600_bib28","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1073\/pnas.0905524107","article-title":"Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated","volume":"107","author":"McPherson","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070905433778600_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1253319","article-title":"Editorial: neuroendocrine tumors: the road to precision medicine","volume":"14","author":"La Salvia","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026070905433778600_bib30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1055\/s-2007-978952","article-title":"Proliferation of pancreatic islet-cells in cyclic and pregnant rats after treatment with progesterone","volume":"30","author":"Nieuwenhuizen","year":"1998","journal-title":"Horm Metab Res"},{"key":"2026070905433778600_bib31","doi-asserted-by":"crossref","first-page":"15644","DOI":"10.1073\/pnas.202612199","article-title":"Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta -cell proliferation","volume":"99","author":"Picard","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070905433778600_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000381455","article-title":"Progesterone receptor isoforms A and B in pancreatic neuroendocrine tumor","volume":"101","author":"Yazdani","year":"2015","journal-title":"Neuroendocrinology"},{"key":"2026070905433778600_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jsbmb.2018.01.003","article-title":"Progesterone arrested cell cycle progression through progesterone receptor isoform A in pancreatic neuroendocrine neoplasm","volume":"178","author":"Yazdani","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026070905433778600_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000326820","article-title":"Immunohistochemical expression and prognostic value of ER, PR and HER2\/neu in pancreatic and small intestinal neuroendocrine tumors","volume":"93","author":"Arnason","year":"2011","journal-title":"Neuroendocrinology"},{"key":"2026070905433778600_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/ejendo\/lvae163","article-title":"Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumors","volume":"192","author":"Wang","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"2026070905433778600_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/01.mpa.0000226893.09194.ec","article-title":"Estrogen receptors in pancreatic tumors","volume":"33","author":"Satake","year":"2006","journal-title":"Pancreas"},{"key":"2026070905433778600_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/annonc\/10.suppl_4.S131","article-title":"Other risk factors for pancreatic cancer: hormonal aspects","volume":"10","author":"Andr\u00e9n-Sandberg","year":"1999","journal-title":"Ann Oncol"},{"key":"2026070905433778600_bib38","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3390\/ijms18081713","article-title":"Estrogen, estrogen receptor and lung cancer","volume":"18","author":"Hsu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2026070905433778600_bib39","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1158\/0008-5472.CAN-04-3087","article-title":"Progesterone receptor in non-small cell lung cancer \u2013 a potent prognostic factor and possible target for endocrine therapy","volume":"65","author":"Ishibashi","year":"2005","journal-title":"Cancer Res"},{"key":"2026070905433778600_bib40","first-page":"910","article-title":"Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer","volume":"76","author":"Marquez-Garban","year":"2011","journal-title":"Steroids"},{"key":"2026070905433778600_bib41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.canlet.2016.02.014","article-title":"Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells","volume":"374","author":"Kawprasertsri","year":"2016","journal-title":"Cancer Lett"},{"key":"2026070905433778600_bib42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jsbmb.2019.03.022","article-title":"Progesterone receptor isoform B expression in pulmonary neuroendocrine cells decreases cell proliferation","volume":"190","author":"Asavasupreechar","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026070905433778600_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0012-1606(02)00031-3","article-title":"Hormonal, cellular, and molecular control of prostatic development","volume":"253","author":"Marker","year":"2003","journal-title":"Dev Biol"},{"key":"2026070905433778600_bib44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1677\/erc.0.0060503","article-title":"Neuroendocrine cells in tumour growth of the prostate","volume":"6","author":"Abrahamsson","year":"1999","journal-title":"Endocr Relat Cancer"},{"key":"2026070905433778600_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/pros.2990190202","article-title":"Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate","volume":"19","author":"Bonkhoff","year":"1991","journal-title":"Prostate"},{"key":"2026070905433778600_bib46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fonc.2014.00060","article-title":"The many faces of neuroendocrine differentiation in prostate cancer progression","volume":"4","author":"Terry","year":"2014","journal-title":"Front Oncol"},{"key":"2026070905433778600_bib47","first-page":"1809","article-title":"LNCaP model of human prostatic carcinoma","volume":"43","author":"Horoszewicz","year":"1983","journal-title":"Cancer Res"},{"key":"2026070905433778600_bib48","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1210\/me.2003-0031","article-title":"Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells","volume":"17","author":"Wright","year":"2003","journal-title":"Mol Endocrinol"},{"key":"2026070905433778600_bib49","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.eururo.2003.11.032","article-title":"Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy","volume":"45","author":"Hirano","year":"2004","journal-title":"Eur Urol"},{"key":"2026070905433778600_bib50","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.eururo.2005.03.017","article-title":"Changes in chromogranin A serum levels during endocrine therapy in metastatic prostate cancer patients","volume":"48","author":"Sasaki","year":"2005","journal-title":"Eur Urol"},{"key":"2026070905433778600_bib51","first-page":"4687","article-title":"Androgen-independent prostate cancer progression in the TRAMP model","volume":"57","author":"Gingrich","year":"1997","journal-title":"Cancer Res"},{"key":"2026070905433778600_bib52","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aah4199","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku","year":"2017","journal-title":"Science"},{"key":"2026070905433778600_bib53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aah4307","article-title":"SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer","volume":"355","author":"Mu","year":"2017","journal-title":"Science"},{"key":"2026070905433778600_bib54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-3-319-22542-5_3","article-title":"Epidemiology and clinical presentation of medullary thyroid carcinoma","volume":"204","author":"Raue","year":"2015","journal-title":"Recent Results Cancer Res"},{"key":"2026070905433778600_bib55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.23736\/S2724-6507.23.04017-4","article-title":"Calcium-stimulated calcitonin test for the diagnosis of medullary thyroid cancer: results of a multicenter study and comparison between different assays","volume":"48","author":"Faggiano","year":"2023","journal-title":"Minerva Endocrinol"},{"key":"2026070905433778600_bib56","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40618-020-01356-9","article-title":"Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment","volume":"44","author":"Fugazzola","year":"2021","journal-title":"J Endocrinol Investig"},{"key":"2026070905433778600_bib57","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0003-4266(06)72585-9","article-title":"C-cell hyperplasia","volume":"67","author":"Guy\u00e9tant","year":"2006","journal-title":"Ann Endocrinol"},{"key":"2026070905433778600_bib58","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/8756-3282(90)90132-I","article-title":"Estrogen receptors appear undetectable in the C-cells of the human thyroid gland","volume":"11","author":"Fr\u00f8lich","year":"1990","journal-title":"Bone"},{"key":"2026070905433778600_bib59","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.MP.0000066800.44492.1B","article-title":"Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions","volume":"16","author":"Kawabata","year":"2003","journal-title":"Mod Pathol"},{"key":"2026070905433778600_bib60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1677\/jme.0.0240145","article-title":"Immunolocalisation of oestrogen receptor beta in human tissues","volume":"24","author":"Taylor","year":"2000","journal-title":"J Mol Endocrinol"},{"key":"2026070905433778600_bib61","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00428-007-0379-6","article-title":"Expression of sex steroid hormone receptors in C cell hyperplasia and medullary thyroid carcinoma","volume":"450","author":"Bl\u00e9chet","year":"2007","journal-title":"Virchows Arch"},{"key":"2026070905433778600_bib62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1385\/EP:14:2:159","article-title":"Androgen receptor expression in C-cells and in medullary thyroid carcinoma","volume":"14","author":"Zhai","year":"2003","journal-title":"Endocr Pathol"},{"key":"2026070905433778600_bib63","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1210\/endo-118-6-2594","article-title":"Effects of estradiol and progesterone on calcitonin secretion","volume":"118","author":"Greenberg","year":"1986","journal-title":"Endocrinology"},{"key":"2026070905433778600_bib64","first-page":"2760","article-title":"Estrogen receptor and hormone responsiveness of medullary thyroid carcinoma cells in continuous culture","volume":"48","author":"Yang","year":"1988","journal-title":"Cancer Res"},{"key":"2026070905433778600_bib65","first-page":"1065","article-title":"Effects of tamoxifen and somatostatin analogue on growth of human medullary, follicular, and papillary thyroid carcinoma cell lines: tissue culture and nude mouse xenograft studies","volume":"108","author":"Weber","year":"1990","journal-title":"Surgery"},{"key":"2026070905433778600_bib66","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000488996","article-title":"Immune checkpoint inhibitors in the treatment of patients with neuroendocrine neoplasia","volume":"41","author":"Weber","year":"2018","journal-title":"Oncol Res Treat"},{"key":"2026070905433778600_bib67","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2265.1987.tb01184.x","article-title":"Does testosterone influence the post-stimulatory levels of calcitonin in normal men?","volume":"27","author":"Garcia-Ameijeiras","year":"1987","journal-title":"Clin Endocrinol"},{"key":"2026070905433778600_bib68","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1677\/JOE-06-0193","article-title":"Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis","volume":"195","author":"Cho","year":"2007","journal-title":"J Endocrinol"},{"key":"2026070905433778600_bib69","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jsbmb.2012.06.006","article-title":"Anti-proliferative effects of a novel isoflavone derivative in medullary thyroid carcinoma: an in vitro study","volume":"132","author":"Greenman","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026070905433778600_bib70","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/hmg\/ddw057","article-title":"Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression","volume":"25","author":"Smith","year":"2016","journal-title":"Hum Mol Genet"},{"key":"2026070905433778600_bib71","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231186041","article-title":"HORMONET: a phase II trial of tamoxifen for estrogen\/progesterone receptor-positive neuroendocrine tumors","volume":"15","author":"Barros","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"2026070905433778600_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105694","article-title":"Progesteron receptor expression in insulin producing cells of neuroendocrine neoplasms","volume":"201","author":"Tachibana","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026070905433778600_bib73","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/JOE-13-0202","article-title":"Progesterone induces apoptosis of insulin-secreting cells: insights into the molecular mechanism","volume":"221","author":"Nunes","year":"2014","journal-title":"J Endocrinol"},{"key":"2026070905433778600_bib74","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/1097-0142(19921101)70:9<2268::AID-CNCR2820700910>3.0.CO;2-X","article-title":"Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin","volume":"70","author":"Viale","year":"1992","journal-title":"Cancer"},{"key":"2026070905433778600_bib75","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.5858\/arpa.2013-0195-OA","article-title":"Progesterone receptor and PTEN expression predict survival in patients with low- and intermediate-grade pancreatic neuroendocrine tumors","volume":"138","author":"Estrella","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"2026070905433778600_bib81","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4132\/jptm.2017.03.19","article-title":"Loss of progesterone receptor expression is an early tumorigenesis event associated with tumor progression and shorter survival in pancreatic neuroendocrine tumor patients","volume":"51","author":"Kim","year":"2017","journal-title":"J Pathol Transl Med"},{"key":"2026070905433778600_bib76","first-page":"209","article-title":"Long term treatment with tamoxifen for metastatic carcinoid tumor","volume":"89","author":"Arganini","year":"1989","journal-title":"Acta Chir Belg"},{"key":"2026070905433778600_bib77","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.5301\/tj.5000259","article-title":"Small-bowel neuroendocrine tumor and retroperitoneal fibrosis: efficacy of octreotide and tamoxifen","volume":"101","author":"Biasco","year":"2015","journal-title":"Tumori"},{"key":"2026070905433778600_bib78","doi-asserted-by":"crossref","first-page":"531","DOI":"10.7326\/0003-4819-100-4-531","article-title":"Tamoxifen therapy for metastatic carcinoid tumor: a negative study","volume":"100","author":"Moertel","year":"1984","journal-title":"Ann Intern Med"},{"key":"2026070905433778600_bib79","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0303-7207(01)00750-X","article-title":"Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue","volume":"188","author":"Fasco","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"2026070905433778600_bib80","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.5858\/132.12.1889","article-title":"Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors","volume":"132","author":"Sica","year":"2008","journal-title":"Arch Pathol Lab Med"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/32\/9\/ERC-25-0164.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/32\/9\/ERC-25-0164.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0164\/145094\/erc-25-0164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0164\/145094\/erc-25-0164.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:43:53Z","timestamp":1783590233000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/32\/9\/e250164\/25927\/Impact-of-sex-hormones-on-development-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":81,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0164","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"article-number":"e250164"}}